The Canadian marijuana stocks we’ve identified today have seen consistent stock-price growth year-to-date
SmallCapPower | February 8, 2018: Today we have weeded out four Canadian marijuana stocks with the strongest stock price charts since the beginning of the year. A strong stock chart is represented by consistent growth in share price while limiting the prevalence of significant share-price decrease or fluctuations. On average, the stocks on our list have yielded returns of 75% YTD. For investors, these stocks have a history of significant upside moves over short time periods.
*Share prices as at close February 6, 2019, data obtained from S&P Capital IQ.
For Our Complete Coverage Of Canadian Marijuana Stocks Click Here
Cronos Group Inc. (TSX:CRON) – $25.93
Cannabis
Cronos Group operates two wholly-owned Canadian licensed producers and has international production and distribution across five continents. The Company is focused on rapidly expanding its global footprint through building an international iconic brand portfolio and developing disruptive intellectual property. On December 7, 2018, the Company announced a $2.5B investment from Altria Group (NYSE:MO), the cigarette maker behind Marlboro. On January 23, Cronos Group announced it had received a $65M credit facility co-led CIBC and BMO.
- YTD Return: 89%
- Market Cap: $5,100 million
- Average Daily Volume – 30 Days: 3,342,000
- Average Daily Volume – 100 Days: 2,374,000
Khiron Life Sciences Corp. (TSXV:KHRN) – $2.78
Cannabis
Khiron Life Sciences is a Canadian medical cannabis company with operations in Colombia. The Company works with the scientific and medical-based research applications for cannabis and currently has an estimated potential market of 6M for patients in Colombia, with 68M patients throughout Latin America, upon future expansion. On November 27, 2018, the Company announced government approval to commercialize and market its Kuida CBD cosmeceutical product line in Peru. On January 25, the Company’s share price surged 19% to $2.35 after announcing a binding letter of intent to establish a joint venture with Dixie Brands Inc. (CSE:DIXI.U) to introduce cannabis-infused products in Latin America.
- YTD Return: 82%
- Market Cap: $211.1 million
- Average Daily Volume – 30 Days: 1,330,000
- Average Daily Volume – 100 Days: 826,000
Canopy Growth Corporation (TSX:WEED) – $61.38
Cannabis
Canopy Growth is the largest cannabis company on the NYSE and TSX, listed by market cap, and was the first cannabis company to be publicly traded in North America. The Company has been able to strategically position itself in Canada’s recreational market by securing a variety of agreements with the provinces of Quebec, Prince Edward Island, New Brunswick, and Newfoundland & Labrador. With the largest licensed production platform in Canada, the Company strives to maintain its leading market position by looking for new growth opportunities, including its December 6, 2018 acquisition of Storz & Bickel, a German vape company, in a deal valued at $221M. Recently, the Company has been making moves in the hemp market, announcing on January 14 its license by New York State to process and produce hemp.
- YTD Return: 67%
- Market Cap: $21,055.0 million
- Average Daily Volume – 30 Days: 4,772,000
- Average Daily Volume – 100 Days: 3,987,000
Aphria Inc. (TSX:APHA) – $12.80
Cannabis
Aphria is one of the largest cannabis producers by licensed capacity in Canada. The Company’s greenhouse facility in Leamington provides it with scalable, low-cost production of medicinal cannabis. The Company sells medical marijuana and its derivatives through wholesale channels and retail sales. By the beginning of 2019, Aphria hopes to increase its cumulative growing space to 1,000,000 sq. ft. and increase its annual production capacity to 100,000 kg. On December 3, 2018, Hindenburg Research released a short-seller report accusing the Company of purchasing its Latin American assets at inflated prices to benefit the Company’s executives and insiders. On December 28, Green Growth Brands (CSE:GGB) announced a hostile takeover bid for Aphria at $11/share, which the Company rejected on February 6, stating that the offer significantly undervalued the company.
- YTD Return: 63%
- Market Cap: $3,202.0 million
- Average Daily Volume – 30 Days: 9,541,000
- Average Daily Volume – 100 Days: 10,225,000
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
